Aktiesnakken — Marts 2010
-
22 februar 2010 af Ana Belén Enfedaque Buisán
BioPorto Diagnostics bebuder præsentation af en ny videnskabelig undersøgelse, der omfatter data, der opnås med NGAL test - selskabets kommende diagnostisk test for akut nyre skade snart skal introducere
-
Hall? Velkommen i klubben??
-
er din egen punkteret gobe?
-
weeeeee Genmab fører C20
-
weeeee
-
weeeeeeeeeeeeeeeeeee
-
weeeeeeeeeeeeeeeeeeee
-
Genmab sprinter afsted, skarpt forfulgt af Nordea, der er nu kun 1 time og 18 minutter til målstregen, kan se at novozymes trækker op på
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind